Митчелл Клионски – Используйте голову, чтобы спасти мозг. Профилактика деменции в любом возрасте (страница 42)

Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A III. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005;82(3):627–635. doi: 10.1093/ajcn.82.3.627

Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S4–S8. doi: 10.2215/CJN.01490506

Xu W, Tan L, Wang HF, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2015;86(12):1299–1306. doi: 10.1136/jnnp-2015-310548. Epub 2015 Aug 20.

Yassine HN, Braskie MN, Mack WJ, et al. Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E ε4 carriers: a review. JAMA Neurol. 2017;74(3):339–347. doi: 10.1001/jamaneurol.2016.4899

Zhao C, Tsapanou A, Manly J, Schupf, N, Brickman AM, Gu, Y. Vitamin D intake is associated with dementia risk in the Washington Heights – Inwood Columbia Aging Project (WHICAP). Alzheimers Dement. 2020;16:1393–1401. doi: 10.1002/alz.12096

Alexander CM, Seifert HA, Blouin RT, Conrad PF, Gross JB. Diphenhydramine enhances the interaction of hypercapnic and hypoxic ventilatory drive. Anesthesiology. 1994;80:789–795.

Boeuf-Cazou O, Bongue B, Ansiau D, Marquie J-C, Lapeyre-Mestre M. Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort. Eur J Clin Pharmacol. 2011;67:1045. doi: 10.1007/s00228-011-1047-y

Campbell NL, Holden R, Boustani MA. Preventing Alzheimer disease by deprescribing anticholinergic medications. JAMA Intern Med. 2019;179(8):1093–1094. doi: 10.1001/jamainternmed.2019.0676

Cohen PA, Avula B, Wang YH, Zakharevich I, Khan I. Five unapproved drugs found in cognitive enhancement supplements. Neurol Clin Pract. 2021;11(3):e303–e307. doi: 10.1212/CPJ.0000000000000960

Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control For Further Reading 245 study. JAMA Intern Med. 2019;179(8):1084–1093. doi: 10.1001/jamaintern

Crowe S, Stranks E. The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis. Arch Clin Neuropsychol. 2018;33:901–911. doi: 10.1093/arclin/acx120

D’Amico G, deFranchis R, Dell’Era A, eds. National history and stages of cirrhosis and variceal hemorrhage. Springer Science+Business Media; 2014. doi: 10.1007/978-1-4939-0002-2_2

Esser MB, Sherk A, Liu Y, et al. Deaths and years of potential life lost from excessive alcohol use – United States, 2011–2015. Morbidity and Mortality Weekly Report. 2020;69:981–987. doi: 10.15585/mmwr.mm6930a1

Flippo TS, Holder WD. Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency. Arch Surg. 1993;128(12):1391–1395. doi: 10.1001/archsurg.1993.01420240099018

Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401–407. doi: 10.1001/jamainternmed.2014.7663

Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986;49:341–345.

He Q, Chen X, Wu T, Li L, Fei X. Risk of dementia in long-term benzodiazepine users: evidence from a meta-analysis of observational studies. J Clin Neurol. 2019;15(1):9–19. doi: 10.3988/jcn.2019.15.1.9. Epub 2018 Oct 26.

Islam MM, Iqbal U, Walther B, et al. Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology. 2016;47:181–191. doi: 10.1159/000454881

Kim JW, Lee DY, Lee BC, et al. Alcohol and cognition in the elderly: a review. Psychiatry Investig. 2012;9:8–16. doi: 10.4306/pi.2012.9.1.8

Kivimäki M, Singh-Manoux A, Batty GD, et al. Association of alcohol-induced loss of consciousness and overall alcohol consumption with risk for dementia. JAMA Netw Open. 2020;3(9):e2016084. doi: 10.1001/jamanetworkopen.2020.16084

National Institute on Alcohol Abuse and Alcoholism. Alcohol facts and statistics. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/alcohol-facts-and-statistics

Oscar-Berman M, Marinkovic K. Alcoholism and the brain: an overview. Alcohol Res Health. 2003;27(2):125–133.

Paterniti S, Dufouil C, Alpérovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol. 2002;22(3):285–293.

Raphael KC, Matuja SS, Shen NT, Liwa AC, Jaka H. Hepatic encephalopathy; prevalence, precipitating factors and challenges of management in a resource-limited setting. J Gastrointest Digest Syst. 2016;6(3):441. doi: 10.4172/2161-069X.1000441

Rösner S, Soyka M, Hajak G, Wehrle R, Englbrecht C. Eszopiclone for insomnia. Cochrane Database System Rev. 2013;8(CD010703). doi: 10.1002/14651858.CD010703

Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508–513. doi: 10.1001/archinternmed.2007.106

Sabia S, Elbaz A, Britton A, Bell S, Dugravot A, Shipley M, Kivimaki M, Singh-Manoux A. Alcohol consumption and cognitive decline in early old age. Neurology. 2014;82(4):332–339. doi: 10.1212/WNL.0000000000000063. Epub 2014 Jan 15.

Sacks O, Shulman M. Steroid dementia: An overlooked diagnosis? Neurology. 2005;64:707–709.

Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J; QalyDays Study Group. Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study. Lancet Public Health. 2018;3(3):e124–132. doi: 10.1016/S2468-2667(18)30022-7. Epub 2018 Feb 21.

Topiwala A, Allan CL, Valkanova V, et al. Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ. 2017;357:j2353. doi: 10.1136/bmj.j2353

Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715–735. doi: 10.1002/hep.27210. Epub 2014 Jul 8.

Weigand AJ, Bondi MW, Thomas KR, et al. Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology. 2020;95(16) e2295–e2304. doi: 10.1212/WNL.0000000000010643

Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology. 2004;39(3):739–745. doi: 10.1002/hep.20095

Wright JD, Cogan JC, Huang Y, et al. Association of new perioperative benzodiazepine use with persistent benzodiazepine use. JAMA Netw Open. 2021;4(6):e2112478. doi: 10.1001/jamanetworkopen.2021.12478

Wu CS, Ting TT, Wang SC, Chang IS, Lin KM. Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry. 2011;19(2):151–159. doi: 10.1097/JGP.Ob013e3181e049ca

Zhang R, Shen L, Miles T, et al. Association of low to moderate alcohol drinking with cognitive functions from middle to older age among US adults. JAMA Netw Open. 2020;3(6):e207922. doi: 10.1001/jamanetworkopen.2020.7922

Bamia C, Trichopoulou A, Trichopoulos D. Age at retirement and mortality in a general population sample: the Greek EPIC study. Am J Epidemiol. 2008;167(5):561–569. doi: 10.1093/aje/kwm337. Epub 2007 Dec 3.

Bialystok E. Bilingualism: pathway to cognitive reserve. Trends Cogn Sci. 2021;25(5):355–364. doi: 10.1016/j.tics.2021.02.003. Epub 2021 Mar 23.

Biddle KD, Jacobs HIL, d’Oleire Uquillas F, et al. Associations of widowhood and β-amyloid with cognitive decline in cognitively unimpaired older adults. JAMA Netw Open. 2020;3(2):e200121. doi: 10.1001/jamanetworkopen.2020.0121

Brenowitz WD, Besser LM, Kukull WA, Keene CD, Glymour MM, Yaffe K. Clinician-judged hearing impairment and associations with neuropathologic burden. Neurology. 2020;95(12):e1640–e1649; doi: 10.1212/WNL.0000000000010575

Bubbico G, Chiacchiaretta P, Parenti M, et al. Effects of second language learning on the plastic aging brain: functional connectivity, cognitive decline, and reorganization. Front Neurosci. 2019;13:423. doi: 10.3389/fnins.2019.00423. eCollection 2019.

Deal JA, Goman AM, Albert MS, et al. Hearing treatment for reducing cognitive decline: design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial. Alzheimer Dement. 2018;4:499–507. doi: 10.1016/j.trci.2018.08.007 248 For Further Reading

Dekhtyar S, Marseglia A, Xu W, Darin-Mattsson A, Wang HX, Fratiglioni L. Genetic risk of dementia mitigated by cognitive reserve: a cohort study. Ann of Neurol. 2019;86(1):68–78. doi: 10.1002/ana.25501. Epub 2019 May 22.

Devere R. Music and dementia: an overview. Pract Neurol. 2017. https://practical neurology.com/articles/2017-june/music-and-dementia-an-overview/pdf

Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF III. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329–335. doi: 10.1192/bjp.bp.112.118307